Literature DB >> 6818348

A clinical and genetic study of Hunter's syndrome. 2. Differences between the mild and severe forms.

I D Young, P S Harper, R G Newcombe, I M Archer.   

Abstract

Entities:  

Mesh:

Year:  1982        PMID: 6818348      PMCID: PMC1048951          DOI: 10.1136/jmg.19.6.408

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


× No keyword cloud information.
  9 in total

1.  Long-term complications in Hunter's syndrome.

Authors:  I D Young; P S Harper
Journal:  Clin Genet       Date:  1979-08       Impact factor: 4.438

2.  Clinical definition of the Hurler-Hunter phenotypes. A review of 50 patients.

Authors:  J G Leroy; A C Crocker
Journal:  Am J Dis Child       Date:  1966-12

3.  Ultrastructure of the rectal wall in Hunter's syndrome.

Authors:  B Elsner
Journal:  Gastroenterology       Date:  1970-06       Impact factor: 22.682

4.  Psychosocial problems in Hunter's syndrome.

Authors:  I D Young; P S Harper
Journal:  Child Care Health Dev       Date:  1981 Jul-Aug       Impact factor: 2.508

5.  Clinical and probable genetic heterogeneity within mucopolysaccharidosis. II. Report of a family with a mild form.

Authors:  J R Lichtenstein; G L Bilbrey; V A McKusick
Journal:  Johns Hopkins Med J       Date:  1972-12

6.  Carpal tunnel syndrome in pediatric mucopolysaccharidoses. Report of four cases.

Authors:  M E Miner; R N Schimke
Journal:  J Neurosurg       Date:  1975-07       Impact factor: 5.115

7.  Multiple peripheral nerve entrapments. An unusual phenotypical variant of the Hunter syndrome (mucopolysaccharidosis II) in a family.

Authors:  G Karpati; S Carpenter; A A Eisen; L S Wolfe; W Feindel
Journal:  Arch Neurol       Date:  1974-12

8.  Myelopathy in mucopolysaccharidosis type II (Hunter syndrome).

Authors:  C E Ballenger; T R Swift; R T Leshner; T A El Gammal; T F McDonald
Journal:  Ann Neurol       Date:  1980-04       Impact factor: 10.422

9.  Peripheral nerve involvement in Hunter syndrome (mucopolysaccharidosis II).

Authors:  T R Swift; T F McDonald
Journal:  Arch Neurol       Date:  1976-12
  9 in total
  35 in total

1.  Mucopolysaccharidosis Type II and the G374sp Mutation.

Authors:  E Martínez-Quintana; F Rodríguez-González
Journal:  Mol Syndromol       Date:  2013-02-13

2.  Long-term follow-up following bone marrow transplantation for Hunter disease.

Authors:  A Vellodi; E Young; A Cooper; V Lidchi; B Winchester; J E Wraith
Journal:  J Inherit Metab Dis       Date:  1999-06       Impact factor: 4.982

3.  Deep Genotyping of the IDS Gene in Colombian Patients with Hunter Syndrome.

Authors:  Johanna Galvis; Jannet González; Alfredo Uribe; Harvy Velasco
Journal:  JIMD Rep       Date:  2015-02-15

4.  Mutational and structural analysis of Japanese patients with mucopolysaccharidosis type II.

Authors:  Tomomi Kato; Zenichiro Kato; Izumi Kuratsubo; Noboru Tanaka; Tabito Ishigami; Jun-Ichi Kajihara; Kazuko Sukegawa-Hayasaka; Koji Orii; Koji Isogai; Toshiyuki Fukao; Nobuyuki Shimozawa; Tadao Orii; Naomi Kondo; Yasuyuki Suzuki
Journal:  J Hum Genet       Date:  2005-08-30       Impact factor: 3.172

5.  Sanfilippo syndrome.

Authors:  K S Devi; P Veerraju; B S Rao
Journal:  Indian J Pediatr       Date:  1993 Jul-Aug       Impact factor: 1.967

Review 6.  Behavioural phenotypes of the mucopolysaccharide disorders: a systematic literature review of cognitive, motor, social, linguistic and behavioural presentation in the MPS disorders.

Authors:  E M Cross; D J Hare
Journal:  J Inherit Metab Dis       Date:  2013-02-06       Impact factor: 4.982

7.  Hunter syndrome in an 11-year old girl on enzyme replacement therapy with idursulfase: brain magnetic resonance imaging features and evolution.

Authors:  Renzo Manara; Angelica Rampazzo; Mara Cananzi; Leonardo Salviati; Rodica Mardari; Paola Drigo; Rosella Tomanin; Nicoletta Gasparotto; Elena Priante; Maurizio Scarpa
Journal:  J Inherit Metab Dis       Date:  2010-01-06       Impact factor: 4.982

Review 8.  Expression of the disease on female carriers of X-linked lysosomal disorders: a brief review.

Authors:  Louise L C Pinto; Taiane A Vieira; Roberto Giugliani; Ida V D Schwartz
Journal:  Orphanet J Rare Dis       Date:  2010-05-28       Impact factor: 4.123

9.  Assessment of iduronate-2-sulfatase mRNA expression in Hunter syndrome (mucopolysaccharidosis type II).

Authors:  P L Crotty; C B Whitley
Journal:  Hum Genet       Date:  1992-11       Impact factor: 4.132

10.  Review of the use of idursulfase in the treatment of mucopolysaccharidosis II.

Authors:  T Andrew Burrow; Nancy D Leslie
Journal:  Biologics       Date:  2008-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.